We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+11.68%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.1B
AUM Growth
+$1.76B
(+10%)
Cap. Flow
+$154M
Cap. Flow
% of AUM
0.81%
Top 10 Holdings %
Top 10 Hldgs %
32.12%
Holding
703
New
28
Increased
257
Reduced
281
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nu Holdings
NU
|
+$60.7M |
| 2 |
Johnson & Johnson
JNJ
|
+$58.3M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$54M |
| 4 |
AbbVie
ABBV
|
+$52.9M |
| 5 |
Palo Alto Networks
PANW
|
+$42.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$92.7M |
| 2 |
Emerson Electric
EMR
|
+$57.2M |
| 3 |
Mercado Libre
MELI
|
+$48.9M |
| 4 |
Broadcom
AVGO
|
+$38.9M |
| 5 |
Micron Technology
MU
|
+$37.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.63% |
| 2 | Healthcare | 23.08% |
| 3 | Financials | 11.48% |
| 4 | Consumer Discretionary | 7.78% |
| 5 | Communication Services | 6.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTLS
651
DELISTED
Chart Industries
GTLS
| – | – |
-9,059
| Closed | -$1.49M |
|
652
Guidewire Software
GWRE
$13.9B
| – | – |
-48,986
| Closed | -$11.5M |
|
653
Halliburton
HAL
$26.1B
| – | – |
-11,858
| Closed | -$242K |
|
|
HES
654
DELISTED
Hess
HES
| – | – |
-19,157
| Closed | -$2.65M |
|
655
InterDigital
IDCC
$6.75B
| – | – |
-27,507
| Closed | -$6.17M |
|
656
Leidos
LDOS
$14.4B
| – | – |
-8,375
| Closed | -$1.32M |
|
657
Lumen
LUMN
$6.43B
| – | – |
-11,000
| Closed | -$48.2K |
|
658
Southwest Airlines
LUV
$21.7B
| – | – |
-11,975
| Closed | -$388K |
|
659
MarketAxess Holdings
MKTX
$4.47B
| – | – |
-50,000
| Closed | -$11.2M |
|
660
Maximus
MMS
$3.32B
| – | – |
-7,668
| Closed | -$538K |
|
661
Norwegian Cruise Line
NCLH
$9.53B
| – | – |
-16,274
| Closed | -$330K |
|
662
Omnicom Group
OMC
$22.7B
| – | – |
-21,534
| Closed | -$1.55M |
|
663
Oshkosh
OSK
$8.82B
| – | – |
-2,654
| Closed | -$301K |
|
664
Vaxcyte
PCVX
$7.65B
| – | – |
-74,717
| Closed | -$2.43M |
|
665
Procept Biorobotics
PRCT
$1.02B
| – | – |
-63,125
| Closed | -$3.64M |
|
666
Qfin Holdings
QFIN
$1.68B
| – | – |
-7,000
| Closed | -$304K |
|
667
Replimune Group
REPL
$455M
| – | – |
-171,527
| Closed | -$1.59M |
|
668
Upstart Holdings
UPST
$2.55B
| – | – |
-8,154
| Closed | -$527K |
|
|
VRNA
669
DELISTED
Verona Pharma
VRNA
| – | – |
-216,400
| Closed | -$20.5M |
|
670
Wells Fargo
WFC
$254B
| – | – |
-3,135
| Closed | -$251K |
|
671
Wynn Resorts
WYNN
$10.3B
| – | – |
-8,802
| Closed | -$825K |
|
672
Zai Lab
ZLAB
$2.07B
| – | – |
-238,897
| Closed | -$8.35M |
|
|
DAY
673
DELISTED
Dayforce
DAY
| – | – |
-12,991
| Closed | -$720K |
|
|
RAL
674
Ralliant Corp
RAL
$7.5B
| – | – |
-25,751
| Closed | -$1.25M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q3 2025 Portfolio in Review
As of Q3 2025, Candriam SCA held 703 positions worth $19.1B, up 10% from $17.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Candriam SCA's Q3 2025 filing shows 28 new, 257 increased, 281 reduced and 39 closed positions. Its largest new stake was Banco Macro: 322,600 shares worth $13.6M. The largest sale was NVIDIA, an estimated $92.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.
- Candriam SCA's largest Q3 2025 buy was Banco Macro: 322,600 shares worth $13.6M.
- Candriam SCA added most to Nu Holdings in Q3 2025, an estimated $60.7M increase.
- Candriam SCA's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $92.7M.
- Candriam SCA fully exited Verona Pharma in Q3 2025, selling an estimated $20.5M.
- Candriam SCA's ten largest holdings make up 32% of its $19.1B portfolio in Q3 2025.
- Candriam SCA opened 28 new positions and closed 39 in Q3 2025.
- Candriam SCA's portfolio value rose 10% quarter-over-quarter to $19.1B.
Based on Candriam SCA's 13F filing for Q3 2025, filed 6 Nov 2025.